|
基于2019年版医保药品目录的变化探讨医院用药管理策略 |
Discussion on the strategy of hospital medication management based on the changes of medical insurance drug catalogue in 2019 |
投稿时间:2020-05-25 修订日期:2020-10-27 |
DOI: |
中文关键词: 基本医疗保险 药品目录 合理用药 管理 |
英文关键词: basic medical insurance drug catalogue rational drug use administration |
基金项目: |
|
摘要点击次数: 354 |
全文下载次数: 0 |
中文摘要: |
2019年版《药品目录》常规准入部分共2643个品种,在2017年版《药品目录》基础上调出150个品种,调入148个品种,谈判成功并纳入目录97个品种。调整后药品结构发生了较大变化,对支付范围的限定更加精准,利于医院药品结构的优化、规范用药管理和减轻医保患者负担。本文通过对2019年版《药品目录》的特点及变化进行分析,并就药品目录调整后对医院用药管理的影响及加强用药管理的途径和办法进行探讨。 |
英文摘要: |
A total of 2643 varieties were included in the regular access section of the drug catalogue in 2019. 150 varieties were transferred out and 148 varieties were transferred in on the basis of the 2017 version of drug catalogue, and 97 varieties were included in the catalogue after successful negotiation. After the adjustment, the drug structure has changed greatly, and the limitation of the payment scope is more accurate, which is conducive to the optimization of the drug structure of the hospital, the standardization of drug management and the reduction of the burden of medical insurance patients. This paper analyzes the characteristics and changes of drug catalogue 2019, and discusses the influence of drug catalogue adjustment on hospital drug administration and the ways and means to strengthen drug administration. |
View Fulltext
查看/发表评论 下载PDF阅读器 |
关闭 |